Supplement: The future of JAK1 selective inhibitors in rheumatology.
26 Aug, 2021 | 08:30h | UTCHomepage: The future of JAK1 selective inhibitors – Rheumatology
How important is JAK1 selectivity?
JAK1: Number one in the family; number one in inflammation?
Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis
The safety of JAK-1 inhibitors
Clinical use of Jak 1 inhibitors for rheumatoid arthritis
JAK1 selective inhibitors for the treatment of spondyloarthropathies
JAK1 inhibition and inflammatory bowel disease